Your session is about to expire
← Back to Search
Dietary Supplement
Treatment Arm for Coronavirus
N/A
Waitlist Available
Led By James Veltmeyer, MD
Research Sponsored by Therapeutic Solutions International
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if QuadraMune(TM), a natural supplement, can help prevent COVID-19 in high-risk individuals by reducing inflammation and boosting the immune system over a few months.
Eligible Conditions
- Coronavirus
- Coronavirus Infection
- COVID-19
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Prevention of COVID-19
Secondary study objectives
Safety as determined by presence or absence of Adverse Events and Serious Adverse Events
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Treatment ArmExperimental Treatment1 Intervention
Patients will receive 2 pills of QuadraMune(TM) daily for 12 weeks
Find a Location
Who is running the clinical trial?
Therapeutic Solutions InternationalLead Sponsor
2 Previous Clinical Trials
60 Total Patients Enrolled
James Veltmeyer, MDPrincipal InvestigatorTherapeutic Solutions International
1 Previous Clinical Trials
30 Total Patients Enrolled
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger